ENVALITH
株式会社総医研ホールディングス logo

Soiken Holdings Inc.

2385Growth MarketServices

株式会社総医研ホールディングス logo
Soiken Holdings Inc.2385
Reference Indicators

Market Cap

56¥100M

P/E (Forecast)

46.6x

P/B

0.9x

Dividend Yield (Forecast)

4.67%

ROE

-3.5%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2022Jun 2022
2023Jun 2023
2024Jun 2024
2025Jun 2025
Net Sales
9,3478,0795,1584,848
Cost of Sales
5,0874,3642,6762,438
Gross Profit
4,2603,7152,4822,410
SG&A Expenses
3,0512,9903,0922,548
Operating Income
1,208725-610-137
Non-operating Income
472458
Non-operating Expenses
2010
Ordinary Income
1,253727-565-129
Extraordinary Losses
114891
Pre-tax Income
1,252725-614-220
Income Taxes
43526948-9
Net Income
809451-662-210
EBITDA
1,232750-583-119
Gross Margin
45.6%46.0%48.1%49.7%
Operating Margin
12.9%9.0%-11.8%-2.8%
ROA
9.5%5.5%-9.5%-3.1%
ROE
12.8%6.6%-10.6%-3.5%
Segment Performance
Unit: ¥M
2025
SegmentNet SalesOperating IncomeOperating Margin
生体評価システム24283.3%
ヘルスケアサポート68810615.4%
化粧品1,506271.8%
健康補助食品2,127914.3%
機能性素材開発282-28-9.9%